Skip to content
ppharmaranks
Menu

Suboxone Tooth Decay Lawsuit

buprenorphine / naloxone · Indivior · updated June 2026

Suboxone sublingual film faces a mass tort alleging that its acidic formulation causes severe tooth decay, erosion, and tooth loss. The FDA added a dental-problems warning to mouth-dissolved buprenorphine medicines in 2022.

This page is general information about ongoing litigation and FDA safety actions — not medical or legal advice, and not a statement that Suboxone caused any injury. Allegations described here are claims that have not been proven in court. Always consult a licensed professional.

What the lawsuits allege

Plaintiffs allege Indivior failed to warn that the acidic buprenorphine/naloxone film can cause severe dental erosion, decay, and tooth loss.

  • Severe tooth decay
  • Dental erosion
  • Tooth loss

FDA action

In January 2022 the FDA required a warning about dental problems be added to buprenorphine medicines that dissolve in the mouth.

Verify against the current FDA-approved label: Suboxone label on DailyMed (U.S. NLM).

Where the litigation stands

As of mid-2026, about 1,800 cases — with plaintiff-side trackers reporting more than 10,000 individual claims filed or anticipated — are consolidated in MDL 3092 in the Northern District of Ohio. No settlement has been reached; bellwether trials are expected around 2028.

Case counts and MDL status are published by the U.S. Judicial Panel on Multidistrict Litigation — JPML pending MDLs. Any figure not on the court record is attributed to the secondary legal-press links below.

Who may be affected

The Suboxone lawsuits are brought by people who say they used Suboxone (buprenorphine / naloxone) and were later diagnosed with one or more of the alleged injuries above. Whether any individual situation could support a claim depends on the specific facts, the medical records, and each state's filing deadline (statute of limitations) — which can expire, so timing matters. Only a licensed attorney can evaluate a specific case. This page is general information, not legal advice.

Frequently asked

What is the Suboxone lawsuit about?
Plaintiffs allege Indivior failed to warn that the acidic buprenorphine/naloxone film can cause severe dental erosion, decay, and tooth loss. As of mid-2026, about 1,800 cases — with plaintiff-side trackers reporting more than 10,000 individual claims filed or anticipated — are consolidated in MDL 3092 in the Northern District of Ohio. No settlement has been reached; bellwether trials are expected around 2028.
What injuries are alleged in the Suboxone lawsuits?
Lawsuits allege severe tooth decay, dental erosion, tooth loss. These are allegations; a court has not found that Suboxone causes them.
Has the FDA acted on Suboxone?
In January 2022 the FDA required a warning about dental problems be added to buprenorphine medicines that dissolve in the mouth.
Is there a deadline to file a Suboxone lawsuit?
Yes — every state sets a filing deadline (statute of limitations) for product-injury claims, often running from the date of injury or diagnosis, and once it passes a claim is usually barred. The exact window varies by state and circumstances, so anyone considering a claim should check with a licensed attorney promptly. This is general information, not legal advice.

Our independent rating

Other drug-safety & lawsuit trackers

See all safety & litigation trackers →

Sources